Aeon Biopharma Stock Alpha and Beta Analysis
| AEON Stock | 1.10 0.02 1.85% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AEON Biopharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in AEON Biopharma over a specified time horizon. Remember, high AEON Biopharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AEON Biopharma's market risk premium analysis include:
Beta (1.53) | Alpha 0.78 | Risk 7.74 | Sharpe Ratio 0.0912 | Expected Return 0.71 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out AEON Biopharma Backtesting, AEON Biopharma Valuation, AEON Biopharma Correlation, AEON Biopharma Hype Analysis, AEON Biopharma Volatility, AEON Biopharma History and analyze AEON Biopharma Performance. AEON Biopharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AEON Biopharma market risk premium is the additional return an investor will receive from holding AEON Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AEON Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AEON Biopharma's performance over market.| α | 0.78 | β | -1.53 |
AEON Biopharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of AEON Biopharma's Buy-and-hold return. Our buy-and-hold chart shows how AEON Biopharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.AEON Biopharma Market Price Analysis
Market price analysis indicators help investors to evaluate how AEON Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AEON Biopharma shares will generate the highest return on investment. By understating and applying AEON Biopharma stock market price indicators, traders can identify AEON Biopharma position entry and exit signals to maximize returns.
AEON Biopharma Return and Market Media
The median price of AEON Biopharma for the period between Sat, Oct 4, 2025 and Fri, Jan 2, 2026 is 0.92 with a coefficient of variation of 14.04. The daily time series for the period is distributed with a sample standard deviation of 0.13, arithmetic mean of 0.93, and mean deviation of 0.1. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Will AEON Biopharma Inc. outperform the market - Weekly Stock Recap Low Risk Entry Point Guides - newser.com | 10/23/2025 |
2 | Acquisition by Carter Eric G of 16260 shares of AEON Biopharma, at 14.4 subject to Rule 16b-3 | 11/05/2025 |
3 | AEON Biopharma Reports Positive and Robust Biosimilarity Results Identical Amino Acid Sequence and Highly Similar Functional Analysis Data | 11/13/2025 |
4 | AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth | 11/14/2025 |
5 | Will AEON Biopharma Inc. Class stock beat international competition - Earnings Trend Report Precise Trade Entry Recommendations - newser.com | 11/17/2025 |
6 | AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling | 11/20/2025 |
7 | Can AEON Biopharma Inc. Class stock retain market dominance - July 2025 Fed Impact Growth Focused Entry Point Reports - Newser | 12/02/2025 |
8 | How AEON Biopharma Inc. Class stock performs in volatility spikes - Quarterly Market Review Fast Gain Stock Trading Tips - Newser | 12/04/2025 |
9 | AEON Biopharma Announces Execution of Exchange Agreement with Daewoong | 12/15/2025 |
10 | What insider trading reveals about AEON Biopharma Inc. stock - 2025 Technical Patterns Growth Focused Entry Reports - | 12/18/2025 |
11 | Aug EndMonth How AEON Biopharma Inc stock benefits from global expansion - Weekly Profit Recap Risk Managed Investment Strategies - moha.gov.vn | 12/24/2025 |
12 | AEON integrates scan-to-pay technology with OKXs X Layer network | 12/31/2025 |
About AEON Biopharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AEON or other stocks. Alpha measures the amount that position in AEON Biopharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Interest Debt Per Share | 27.57 | 26.19 | Revenue Per Share | 14.09 | 15.72 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AEON Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AEON Biopharma's short interest history, or implied volatility extrapolated from AEON Biopharma options trading.
Build Portfolio with AEON Biopharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out AEON Biopharma Backtesting, AEON Biopharma Valuation, AEON Biopharma Correlation, AEON Biopharma Hype Analysis, AEON Biopharma Volatility, AEON Biopharma History and analyze AEON Biopharma Performance. To learn how to invest in AEON Stock, please use our How to Invest in AEON Biopharma guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
AEON Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.